Search Results
Search results for "new hampshire"
244 results found for "new hampshire"
- MPOX and Beyond - Reforming Emergency Response
New data from the Centers for Disease Control and Prevention (CDC) indicates a troubling resurgence of This surge, particularly in regions like New York City, DC/Virginia, California, and Florida, underscores strain of the virus circulating with a fatality rate of nearly 1 in 10, alongside the virus' spread into new areas, new populations (including sex workers), and in new ways – including sexually – and evading diagnostic investment, policy reform, and sustained advocacy to dismantle the chronic failures that turn each new
- Return of the Flu: Flurona, a Co-occurring Infection that is NOT
United States in earnest, with the Centers of Disease Control and Prevention reporting about 1.3 million new This co-occurring infection, however, isn’t new. The relationship between the public, experts, and news media is deeply damaged by practices of all parties – a busy public less interested in reading longer, more detail articles, a news media competing for
- Louisiana Sent a Fifth of Its Opioid Settlement to Sheriffs. The Results Were Predictable.
Because sheriffs in Louisiana are elected and hold independent budgets, reporters from KFF Health News , The Current, Gulf States Newsroom, and Verite News had to build the first detailed accounting themselves penitentiary in 1975, Louisiana found it cheaper to pay sheriffs to hold the overflow than to build new New Orleans homicides fell for two straight years, down 35% in 2024, a turnaround that predated the special The escalation continued into 2026: on August 1, a new law made cannabis possession within 2,000 feet
- America's Vaccination Problem
serious resurgence of vaccine-preventable diseases, exemplified by the measles outbreak in Texas and New In a rapid succession of alarming developments within a single week, we've witnessed a new confirmed Norman Baylor, former director of the FDA's Office of Vaccine Research and Review, told NBC News: "I'm This case adds to outbreaks in nine states, including Texas, New Mexico, Alaska, Georgia, New Jersey, New York, and Rhode Island.
- Troubling Issues with HIV and Monkeypox Co-Infection
access to vaccine and antiviral supplies, HIV and MPV co-infection risk and reporting, and the latest news municipal jurisdictions that were specifically targeted for JYNNEOS vaccine supplies—Los Angeles, Chicago, New eight jurisdictions: California Los Angeles San Francisco District of Columbia Georgia Illinois Chicago New York (excluding New York City) These jurisdictions were selected because they were independently funded The disparities faced by those bearing the brunt of MPV mirror those in new HIV diagnoses; it is incumbent
- Healthcare in the Lame Duck
the White House in January 2025 and Republicans poised to control both chambers of Congress in the new healthcare priorities, create a complex landscape for deciding which items are addressed before the new This would create new hurdles for maintaining adherence to treatment regimens and managing ongoing care Advocates fear that with a new majority eager to trim budgets and revisit healthcare spending priorities Monitor Agency Leadership and Policy Shifts: Staying informed about new federal health agency leaders
- CANN Grows to Meet Need
enormous and remains deeply complex as the powers behind interests other than patients have taken on new Our Team CANN’s core team saw the addition of our regular blogger, Travis Manint, and new consultant, As CANN looks toward the new year (and the years to come), we will continue to seek out people affected dose of antiretroviral medication – they have lived for more than a decade with HIV and ARVs aren’t “new Imagine, empathize with being bed ridden or fearful of leaving home, awaiting news you need a lung transplant
- Reducing Medication Abandonment; Improving Retention in Care
Not only did medication cost-sharing increase on new brand name medications, the out-of-pocket costs On average, Black patients were 7% more likely to abandon new medications than their white peers. pre-exposure prophylaxis for the prevention of HIV (PrEP) with Black patients 41% more likely to abandon a new
- When Anti-Equality Means Anti-HIV
Additionally, In the United States, 20% of new HIV diagnoses in 2020 were among young people aged 13- Earlier this month, Iowa Public Radio noted that despite national new HIV infection rates falling overall , Iowa’s new infection rates have remained steadfast.
- Biden Administration's Healthcare Future is One of Promise & Peril
the largest barriers to care and mandating lower drug costs would harm innovation and development of new mandated price negotiation proposals would harm the industry’s ability to invest the development of new as those medications currently “in the pipeline” would largely be safe, but a near 10% reduction in new While new drug development has largely been focused on “personalized” medicine – or more specific treatments vaccine access and threatened the economic future of the globe.To top off all of this policy-making news
- ACA Subsidies in Limbo: What the Senate Framework Means for Patients
Mike Lawler of New York and Robert Bresnahan, Brian Fitzpatrick, and Ryan Mackenzie of Pennsylvania—signed Ron Wyden (D-Ore.) warned Fox News, "I am not going to open the door to Hyde, given what happens and As CANN's December analysis detailed, New York City's 2024 HIV surveillance data showed diagnoses rising for the fourth consecutive year, with 86% of new diagnoses among Black or Latino people and 48% of those changes to covered services—will determine whether a compromise actually improves access or introduces new
- Health Inequity: Barriers Caused by Abusive Payer Practices
The barriers caused by abusive payer practices is nothing new to patients living with chronic health Similarly, the New York Timescovered the issue of payers refusing to cover the cost of high-cost, life-saving entities responsible for McNaughton’s experiences, or those described by the numerous patients included in New Indeed, MCOs and private payers have a history of refusing to add new medications to formularies, arguing The New York Times piece notably reminds readers, when payers or even government officials argue for




